Dazmegrel
Dazmegrel (UK-38485) is a thromboxane synthetase inhibitor which inhibits Thromboxane A2 (TXA2) synthesis and exhibits antiplatelet vasodilator effects. Dazmegrel can be utilized in thrombosis research[1].
Product Specifications
CAS Number
76894-77-4
Product Name Alternative
UK38485
UNSPSC
12352005
Target
Prostaglandin Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/dazmegrel.html
Smiles
O=C(CCN1C2=C(C(CN3C=NC=C3)=C1C)C=CC=C2)O
Molecular Formula
C16H17N3O2
Molecular Weight
283.33
References & Citations
[1]Belch JJ, et al. Platelet changes after a saturated fat meal and their prevention by Dazmegrel, a thromboxane synthetase inhibitor. Lipids. 1987 Mar;22 (3) :159-62.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
39-1046-100 100 µg/Vial
Anti-MAP Kinase, Activated (Diphosphorylated ERK-1&2) Monoclonal Antibody (Clone: MAPK-YT)
Sign In for Pricing
View Details LS140766-100ug 100 µg
ADAMTS14 (NM_139155) Human Over-expression Lysate
Sign In for Pricing
View Details 